192 related articles for article (PubMed ID: 35635656)
1. Complementary omics strategies to dissect p53 signaling networks under nutrient stress.
Galhuber M; Michenthaler H; Heininger C; Reinisch I; Nössing C; Krstic J; Kupper N; Moyschewitz E; Auer M; Heitzer E; Ulz P; Birner-Gruenberger R; Liesinger L; Lenihan-Geels GN; Oster M; Spreitzer E; Zenezini Chiozzi R; Schulz TJ; Schupp M; Madl T; Heck AJR; Prokesch A
Cell Mol Life Sci; 2022 May; 79(6):326. PubMed ID: 35635656
[TBL] [Abstract][Full Text] [Related]
2. Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis.
Prokesch A; Graef FA; Madl T; Kahlhofer J; Heidenreich S; Schumann A; Moyschewitz E; Pristoynik P; Blaschitz A; Knauer M; Muenzner M; Bogner-Strauss JG; Dohr G; Schulz TJ; Schupp M
FASEB J; 2017 Feb; 31(2):732-742. PubMed ID: 27811061
[TBL] [Abstract][Full Text] [Related]
3. Gelsolin negatively regulates the activity of tumor suppressor p53 through their physical interaction in hepatocarcinoma HepG2 cells.
An JH; Kim JW; Jang SM; Kim CH; Kang EJ; Choi KH
Biochem Biophys Res Commun; 2011 Aug; 412(1):44-9. PubMed ID: 21801713
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
5. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
6. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
[TBL] [Abstract][Full Text] [Related]
8. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
[TBL] [Abstract][Full Text] [Related]
9. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
10. A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis.
Higashitsuji H; Higashitsuji H; Nagao T; Nonoguchi K; Fujii S; Itoh K; Fujita J
Cancer Cell; 2002 Oct; 2(4):335-46. PubMed ID: 12398897
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA maintenance is regulated in human hepatoma cells by glycogen synthase kinase 3β and p53 in response to tumor necrosis factor α.
Vadrot N; Ghanem S; Braut F; Gavrilescu L; Pilard N; Mansouri A; Moreau R; Reyl-Desmars F
PLoS One; 2012; 7(7):e40879. PubMed ID: 22911714
[TBL] [Abstract][Full Text] [Related]
12. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
[TBL] [Abstract][Full Text] [Related]
13. Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma.
Zhang Y; Kang R; Liu W; Yang Y; Ding R; Huang Q; Meng J; Xiong L; Guo Z
Int J Biol Sci; 2017; 13(9):1213-1221. PubMed ID: 29104512
[TBL] [Abstract][Full Text] [Related]
14. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha.
Moon WS; Chang K; Tarnawski AS
Hum Pathol; 2004 Apr; 35(4):424-9. PubMed ID: 15116322
[TBL] [Abstract][Full Text] [Related]
16. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
17. [HBxAg enhanced p53 protein accumulation in hepatoma cells].
Zhu M; Dai Y; Zhan R
Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):31-4. PubMed ID: 11869509
[TBL] [Abstract][Full Text] [Related]
18. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89.
Chen GG; Merchant JL; Lai PB; Ho RL; Hu X; Okada M; Huang SF; Chui AK; Law DJ; Li YG; Lau WY; Li AK
Am J Pathol; 2003 Jun; 162(6):1823-9. PubMed ID: 12759240
[TBL] [Abstract][Full Text] [Related]
19. p53 actions on microRNA expression and maturation pathway.
Suzuki HI; Miyazono K
Methods Mol Biol; 2013; 962():165-81. PubMed ID: 23150446
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells.
He M; Zhao M; Shen B; Prise KM; Shao C
Oncogene; 2011 Apr; 30(16):1947-55. PubMed ID: 21132005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
